Correction to: Blood Cancer Journal (2011) 1, e46; doi:10.1038/bcj.2011.46; published online 2 December 2011
Since the publication of their article, the authors have identified errors in Figures 2 and 5 owing to errors in figures assembly.
In Figure 2c, the caspase 9 panel of the HDLM2 cell line and L-428 cell line are inadvertently duplicated. Similarly, Figure 5c included duplicate or incorrect panels of donor control blots.
 Some panels of the control cell lines in Figure 5c could not be retrieved to revise the original figure. The authors have therefore provided a corrected Figure 2c and are replacing the published Figure 5c with a repeat independent experiment. These are shown here.
 These errors have no impact on the results. There is no change in the text or figure legends.
 The authors wish to apologise for any inconvenience caused.
Additional information
The online version of the original article can be found at 10.1038/bcj.2011.46
Rights and permissions
About this article
Cite this article
Derenzini, E., Lemoine, M., Buglio, D. et al. Erratum: The JAK inhibitor AZD1480 regulates proliferation and immunity in Hodgkin lymphoma. Blood Cancer Journal 4, e231 (2014). https://doi.org/10.1038/bcj.2014.57
Published:
Issue Date:
DOI: https://doi.org/10.1038/bcj.2014.57